ObjectiveTo investigate the effect of early intensive antihypertensive therapy on patients with basal ganglia intracerebral hemorrhage and its influence on neurological function deficits. MethodsA total of 100 patients with basal ganglia intracerebral hemorrhage were selected and randomly divided into a control group or an observation group, with 50 cases in each group. Both groups were given basic treatment, based on which the control group was treated with early moderate antihypertensive therapy, while the observation group was treated with early intensive antihypertensive therapy. Both groups were treated for 14 days. The National Institutes of Health Stroke Scale (NIHSS) score, Glasgow Coma Scale (GCS) score, activities of daily living scale (ADL) score, hematoma volume, edema volume, pain Visual Analogue Scale (VAS) score and systolic blood pressure before and after treatment, as well as the occurrence of adverse reactions during treatment were compared between the two groups. ResultsBefore treatment, there was no statistically significant difference in NIHSS score, GCS score, ADL score, hematoma volume, edema volume, pain VAS score or systolic blood pressure between the two groups (all P＞0.05). The NIHSS, GCS and ADL scores of the observation group after 14 days of treatment were better than those of the control group, and the hematoma volume, edema volume, pain VAS score and systolic blood pressure after 24 hours of treatment were less or lower than those of the control group (all P＜0.05). During treatment, there was no statistically significant difference in the occurrence of adverse reactions between the two groups (P＞0.05). ConclusionEarly intensive antihypertensive therapy for patients with basal ganglia intracerebral hemorrhage can reduce systolic blood pressure as soon as possible, control the edema and hematoma volumes, reduce the degree of neurological function deficits, relieve pain, and improve self-care ability, with high safety, which is worth promoting.

无